|
| Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Bullion ~ Forex ~ Sports ~ Technology ~ Health ~ Features |
| Lung Cancer ~ Lung Cancer ~ Breast Cancer ~ Heart attack ~ All Health Topics |
|
Home
/ Health News / 2008 / December 2008 / December 5, 2008 People with deadly lung disease at three-fold heart attack risk |
Diabetic men have similar long-term mortality risks as males with heart disease
Childhood disease unlikely to have killed Travoltas son, say docs
Indian-origin researcher identifies gene that predicts heart attack risk
Sack lunches may not provide adequate nutrients to preschooler
Packing lunch for your child might not be a good idea, for a new study has found that sack lunches may not regularly provide adequate nutrients for the growth and development of young children. ANI
Health-monitoring system helps maintain older adults well-being
Many older adults want to remain active and independent for as long as possible. Now, researchers from University of Missouri suggest that installing health monitoring system can help keep check on the health of the elderly and ensure their privacy. ANI
New drug shows potential to treat angina, other cardiac problems
A compound, designed to prevent chest pains in heart patients, could act as a drug to treat angina and possibly other cardiac pathologies, according to a study on animals. ANI
A new study has revealed that people suffering from idiopathic pulmonary fibrosis (IPF), a deadly lung disease, are three times more likely to suffer a heart attack.
Washington, Dec 5 : A new study has revealed that people suffering from idiopathic pulmonary fibrosis (IPF), a deadly lung disease, are three times more likely to suffer a heart attack.
A research team from University of Nottingham has found that along with an increased risk of heart problems, patients with IPF were 23 percent more likely to have angina, had a 60 percent higher risk of stroke, and a three-fold increased risk of deep vein thrombosis.
"If you look at them over time, people with IPF have roughly a three-fold increased risk of acute coronary syndrome, which is a greater increase than you get from smoking," said Richard B. Hubbard, M.D., British Lung Foundation professor of epidemiology at the University of Nottingham and lead author of the study.
For the study, Hubbard and colleagues analysed the risk of cardiovascular disease in nearly 1,000 patients with IPF and more than 3,500 matched controls.
The researchers also found that those with IPF were more than twice as likely as control subjects to have been prescribed amiodarone, a medication used for irregular heartbeats that has also been implicated as a cause of fibrotic lung disease.
"Future investigations are required to better understand the relationship between IPF and systemic vascular disease as well as the mechanisms shared by the two syndromes," wrote David Zisman, M.D., and Steven Kawut, M.D., in an editorial in the same issue of the journal.
"[I]f a causal association were confirmed... the presence of IPF itself could constitute a sufficiently potent risk factor for coronary artery disease such that more aggressive goals in risk factor modification would be warranted," they added.
ANI
